Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 1

Interventions

Specimen Handling 115Magnetic Resonance Spectroscopy 91Carboplatin 61pembrolizumab 59Biopsy 59Cisplatin 53Nivolumab 49Paclitaxel 41Radiotherapy 39Cyclophosphamide 38Gemcitabine 35Dexamethasone 31Radiation 30Bevacizumab 30Pemetrexed 29atezolizumab 27Etoposide 27olaparib 24Lenalidomide 24Docetaxel 24Doxorubicin 23venetoclax 22durvalumab 22X-Rays 22Vincristine 22Rituximab 22Prednisone 22Leucovorin 22Immunoglobulin G 22Disulfides 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Algorithms × 30 days × Clear all
NCT01806129 2026-06-03

EROS

Eastern Cooperative Oncology Group

Phase NA Active not recruiting
434 enrolled 9 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡